16 Results for "

primate brain

" in MedChemExpress (MCE) Product Catalog:
Products (16)

16 Results for "primate brain" in MCE Product Catalog:

3
3 Cited Publications
Art. -Nr.: HY-103169
CAS. Nr.: 316173-57-6
Reinheit:  99.94%
Target:  

Adenosine Receptor

Forschungsgebiete:  

Neurological Disease

SCH442416 is a potent, selective and brain-penetrant antagonist of adenosine A2A receptor (A2AR), with Kis of 0.048 and 0.5 nM for human and rat A2AR respectively. SCH442416 displays more than 23000-fold selectivity over A1R, A2BR, and A3R (Ki=1111, 10000, and 10000 nM, respectively). SCH442416 can be used for imaging of adenosine A2A receptors in rat and primate brain .
loading...
    loading...
3
3 Cited Publications
Art. -Nr.: HY-12700
CAS. Nr.: 1043495-96-0
Reinheit:  98.75%
RO5256390 is an orally effective trace amine associated receptor 1 (TAAR1) agonist. RO5256390 exhibits pro-cognitive and antidepressant-like properties in rodent and primate models, showing similar brain activation patterns to Olanzapine (HY-14541). RO5256390 blocks compulsive overeating behavior in rats. RO5256390 can inhibit ATP (HY-B2176)-induced TNF secretion in mouse bone marrow-derived macrophages .
loading...
    loading...
Art. -Nr.: HY-152148
CAS. Nr.: 1672691-50-7
Reinheit:  99.26%
Target:  

MAGL

Forschungsgebiete:  

Neurological Disease

JZP-MA-11 is a brain-penetrant positron emission tomography (PET) ligand targeting the brain endocannabinoid α/β-hydrolase domain 6 (ABHD6) enzyme. JZP-MA-11 selectively inhibits ABHD6 with an IC50 value of 126 nM. [18F]JZP-MA-11 has the potential for preclinical evaluation targeting the brain ABHD6 in mice and nonhuman primate (NHP) .
loading...
    loading...
Art. -Nr.: HY-135714
CAS. Nr.: 2134109-20-7
Reinheit:  99.51%
Synonyms: EKZ-001
Forschungsgebiete:  

Neurological Disease Cancer

Bavarostat (EKZ-001) is a blood-brain barrier-permeable, potent HDAC6 inhibitor and PET radiotracer, with an IC50 as low as 17 nM against human HDAC6. Bavarostat can be labeled with 18F and used as a probe to map HDAC6 distribution and measure target occupancy in the brains of non-human primates. Bavarostat also selectively modulates tubulin acetylation, but not histone acetylation. Bavarostat is applicable for research on Alzheimer's disease, other neurodegenerative disorders, and cancers .
loading...
    loading...
Art. -Nr.: HY-175748
CAS. Nr.: 3056154-69-6
MK-7337 is an α-synuclein ligand with an affinity of < 1 nM. MK-7337 labeled with 11C can be used as a PET tracer for neurodegenerative disorders like Parkinson’s disease imagination .
loading...
    loading...
Art. -Nr.: HY-120464
CAS. Nr.: 1226793-34-5
Synonyms: SAM-760
Target:  

5-HT Receptor

Forschungsgebiete:  

Neurological Disease

PF-05212377 (SAM-760) is an inhibitor for serotonin receptor 5-HT6. PF-05212377 is a substrate for P-gp/non-BCRP human transporter. PF-05212377 exhibits blood brain barrier permeability in non-human primates. PF-05212377 can be used for Alzheimer’s Disease research .
loading...
    loading...
Art. -Nr.: HY-163075
CAS. Nr.: 2101953-60-8
Target:  

Sigma Receptor

Forschungsgebiete:  

Others

SYB4 (compound 5) is a PET tracer which suitable for imaging the Sigma-2 Receptor in the brain of nonhuman primates .
loading...
    loading...
Art. -Nr.: HY-103169R
CAS. Nr.: 316173-57-6
Forschungsgebiete:  

Neurological Disease

SCH442416 (Standard) is the analytical standard of SCH442416. This product is intended for research and analytical applications. SCH442416 is a potent, selective and brain-penetrant antagonist of adenosine A2A receptor (A2AR), with Kis of 0.048 and 0.5 nM for human and rat A2AR respectively. SCH442416 displays more than 23000-fold selectivity over A1R, A2BR, and A3R (Ki=1111, 10000, and 10000 nM, respectively). SCH442416 can be used for imaging of adenosine A2A receptors in rat and primate brain .
loading...
    loading...
Art. -Nr.: HY-103164A
CAS. Nr.: 148589-13-3
Synonyms: CSC
Target:  

Endogenous Metabolite

Forschungsgebiete:  

Neurological Disease

8-(3-Chlorostyryl)caffeine (CSC) is an adenosine antagonist with selective activity at the A2a adenosine receptor. 8-(3-Chlorostyryl)caffeine showed 520-fold selectivity in radioligand binding experiments in rat brain. Antagonism of adenylylase by 8-(3-Chlorostyryl)caffeine shows 22-fold selectivity in rat chromaffin cells When 8-(3-Chlorostyryl)caffeine is co-administered with the A1-selective antagonist CPX, It can also further increase exercise activity. 8-(3-Chlorostyryl)caffeine exhibits good MAO-B inhibitory activity in primate mitochondria. 8-(3-Chlorostyryl)caffeine also has excellent A2A receptor affinity .
loading...
    loading...
Art. -Nr.: HY-181351
Forschungsgebiete:  

Neurological Disease

PSN09 is a blood-brain barrier-permeable agonist of PSAM 4-GlyR and PSAM 4-5-HT3 receptors with high affinity. 18F-labeled PSN09 serves as a radiotracer for PET imaging in non-human primates .
loading...
    loading...
Art. -Nr.: HY-183665
CAS. Nr.: 76778-24-0
Target:  

Dopamine Receptor

Forschungsgebiete:  

Neurological Disease

GBR-13119 is a blood-brain barrier-permeable inhibitor of the presynaptic dopamine uptake system. GBR-13119 binds to dopamine uptake sites with high selectivity, without being affected by other neurotransmitter reuptake inhibitors. GBR-13119 exhibits a lipophilic systemic distribution profile with extremely low defluorination in rats, while it shows a differential characteristic of slow striatal washout in the brain of primates. GBR-13119 can serve as a PET tracer to achieve visualized imaging of the striatum in primates, and can reflect MPTP-induced dopaminergic neuron degeneration through reduced uptake. GBR-13119 can be widely applied to studies related to Parkinson's disease and dopaminergic neuron degeneration .
loading...
    loading...
Art. -Nr.: HY-182944
CAS. Nr.: 1265900-99-9
Target:  

GABA Receptor

Forschungsgebiete:  

Neurological Disease

GATT-44 is a blood-brain barrier-permeable, selective GABA transporter 1 (GAT-1) ligand with an IC50 of 126 nM. GATT-44 shows selectivity for GAT-2, GAT-3 and BGT-1 subtypes, and undergoes copper-mediated 18F-radiofluorination. The radiolabeled GATT-44 ([ 18F]GATT-44) exhibits brain uptake, metabolic stability and high GAT-1 binding specificity in non-human primates. GATT-44 is applicable for research on neurodegenerative and neuropsychiatric diseases .
loading...
    loading...
Art. -Nr.: HY-187088
CAS. Nr.: 1198309-73-7
Target:  

mGluR

Forschungsgebiete:  

Neurological Disease

AZD-8418 is an orally active positive allosteric modulator of metabotropic glutamate receptor 2 (mGluR2), with an EC50 of 0.86 μM for rat mGlu2 receptors. AZD-8418 reduces the in vitro binding level of [ 3H]AZ12559322 in prefrontal cortex brain tissues of non-human primates. AZD8418 enhances the inhibitory effect of the mGlu2/3 agonist DCG-IV (HY-101335) on field excitatory postsynaptic potentials (fEPSP) in rat hippocampal brain slices. AZD-8418 reduces nicotine self-administration behavior in rats, and blocks cue-induced reinstatement of nicotine-seeking and food-seeking behaviors. The attenuating effect on nicotine self-administration behavior develops rapid tolerance, while inhibition of food self-administration behavior requires chronic administration. AZD-8418 can be used in research related to nicotine dependence and neuropsychiatric disorders .
loading...
    loading...
Art. -Nr.: HY-108942
CAS. Nr.: 851087-60-0
ASP5854 is an orally active, blood-brain barrier permeable adenosine A1/A2a dual receptor antagonist. ASP5854 blocks receptor activity and agonist-induced intracellular calcium elevation, and exhibits the characteristic of slow dissociation from striatal A2a receptors in primates. ASP5854 reverses catalepsy, enhances cognitive ability, improves motor function and exerts neuroprotective effects, while also alleviating dyskinesia and increasing contralateral turning behavior. ASP5854 is mainly used in studies related to ischemic stroke and Parkinson's disease .
loading...
    loading...
Art. -Nr.: HY-122557
CAS. Nr.: 1259929-13-9
Target:  

5-HT Receptor

Forschungsgebiete:  

Neurological Disease

AZD3676 is an orally active and blood-brain barrier-permeable ligand for 5-HT1 and 5-HT1 receptors, with nanomolar binding affinity. AZD3676 is applicable to research related to cognitive impairment in Alzheimer's disease .
loading...
    loading...
Art. -Nr.: HY-182626
CAS. Nr.: 1246526-29-3
CS1P1 is a brain-penetrant and selective S1PR1 antagonist and PET radiotracer, with human S1PR1 IC50 values of 2.1 nM. CS1P1 binds specifically to S1PR1 to enable in vivo receptor expression quantification. CS1P1 can be used as PET radiotracer when labelled with 11C. CS1P1 can be used for the research of multiple sclerosis, neointimal hyperplasia, vascular inflammation .
loading...
    loading...
  • 1